• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Azido-PEG5-azide

CAS No. 356046-26-9

Azido-PEG5-azide ( —— )

产品货号. M26897 CAS No. 356046-26-9

Azido-PEG5-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
50MG ¥405 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Azido-PEG5-azide
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Azido-PEG5-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • 产品描述
    Azido-PEG5-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    ——
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    356046-26-9
  • 分子量
    332.4
  • 分子式
    C12H24N6O5
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    [N-]=[N+]=NCCOCCOCCOCCOCCOCCN=[N+]=[N-]
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Sun J, et al. Design, synthesis, biological evaluation, and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors. Org Biomol Chem. 2013 Nov 28;11(44):7676-86.
产品手册
关联产品
  • Calmodulin Binding P...

    Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca2+ release .

  • 1,3,6-Tri-O-galloyl-...

    1,3,6-Tri-O-galloyl-beta-D-glucose is a phenolic compound in Black Walnut Kernels. It shows anti-inflammatory activity.

  • Cyclosporin A-Deriva...

    Cyclosporin A-Derivative 1 (Free base) is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1.